Literature DB >> 17494865

Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells.

Katsuya Hirano1, Namie Nomoto, Mayumi Hirano, Fumi Momota, Akiko Hanada, Hideo Kanaide.   

Abstract

Proteinase-activated receptors 1 and 4 (PAR(1) and PAR(4)) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca(2+) requirement for the NO production between PAR(1) and PAR(4). The activation of PAR(1) by the activating peptide (PAR(1)-AP) elevated cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and activated NO production in porcine aortic and human umbilical vein endothelial cells, whereas it had little effect on bovine aortic endothelial cells. PAR(4) activation by PAR(4)-AP consistently induced NO production without an appreciable [Ca(2+)](i) elevation in three types of endothelial cells. The PAR(1)-mediated NO production was significantly inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), whereas the PAR(4)-mediated NO production was resistant. NO production following the PAR(1) and PAR(4) activation was significantly inhibited by pertussis toxin, but it was resistant to a Galpha(q/11) inhibitor, YM254890 [(1R)-1-[(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl-3-[(1R)-1-methoxyethyl]-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17,20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl]-2-methylpropyl rel-(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate]. However, YM254890 abrogated the PAR(1)-mediated Ca(2+) signal. PAR(4)-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase (PI3K) and Akt, as well as by the dominant negative mutant of Akt. The PAR(1)-mediated NO production was relatively resistant to inhibitors of PI3K. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and endothelial NO synthase following the PAR(4) stimulation. In conclusion, PAR(1) and PAR(4) engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR(4) preferably activates Galpha(i/o) and induced NO production in a manner mostly independent of Ca(2+) but dependent on the PI3K/Akt pathway, whereas PAR(1) activates both the Ca(2+)-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494865     DOI: 10.1124/jpet.107.121038

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Radiation as a risk factor for cardiovascular disease.

Authors:  John E Baker; John E Moulder; John W Hopewell
Journal:  Antioxid Redox Signal       Date:  2011-03-23       Impact factor: 8.401

2.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

Review 3.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

4.  Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.

Authors:  Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

Review 5.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 6.  Allosteric modulation of protease-activated receptor signaling.

Authors:  I Canto; U J K Soh; J Trejo
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

7.  Modulation of PAR(1) signalling by benzimidazole compounds.

Authors:  S Asteriti; S Daniele; F Porchia; M T Dell'Anno; A Fazzini; I Pugliesi; M L Trincavelli; S Taliani; C Martini; M R Mazzoni; A Gilchrist
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

8.  Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.

Authors:  Francesco Moccia; Roberto Berra-Romani; Franco Tanzi
Journal:  World J Biol Chem       Date:  2012-07-26

9.  Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.

Authors:  Hiroyuki Suzuki; Evangeline D Motley; Kunie Eguchi; Akinari Hinoki; Heigoro Shirai; Vabren Watts; Laura N Stemmle; Timothy A Fields; Satoru Eguchi
Journal:  Hypertension       Date:  2008-12-08       Impact factor: 10.190

10.  Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4).

Authors:  Margaret R Cunningham; Kathryn A McIntosh; John D Pediani; Joris Robben; Alexandra E Cooke; Mary Nilsson; Gwyn W Gould; Stuart Mundell; Graeme Milligan; Robin Plevin
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.